BioAge, BKV shares end their first trading day flat after earlier gains

September 26, 2024

https://images.mktw.net/im-62450483

Last Updated: Sept. 26, 2024 at 4:35 p.m. ET
First Published: Sept. 26, 2024 at 8:01 a.m. ET

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.

At the closing bell, BioAge’s stock

BIOA stood at $18.31 for a 1.7% gain over its IPO price. Earlier, the stock had been up as much as 30%.

This post was originally published on Market Watch

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…